Mirador Capital Partners LP Raises Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Mirador Capital Partners LP boosted its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 4.0% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 3,666 shares of the medical equipment provider’s stock after buying an additional 140 shares during the quarter. Mirador Capital Partners LP’s holdings in Intuitive Surgical were worth $1,914,000 as of its most recent SEC filing.

Several other institutional investors also recently bought and sold shares of ISRG. Brown Brothers Harriman & Co. increased its holdings in Intuitive Surgical by 45.3% during the second quarter. Brown Brothers Harriman & Co. now owns 2,228 shares of the medical equipment provider’s stock valued at $991,000 after buying an additional 695 shares during the period. Dimensional Fund Advisors LP increased its holdings in Intuitive Surgical by 10.2% during the second quarter. Dimensional Fund Advisors LP now owns 572,934 shares of the medical equipment provider’s stock valued at $254,872,000 after buying an additional 52,976 shares during the period. One Capital Management LLC acquired a new stake in Intuitive Surgical in the second quarter valued at approximately $790,000. Moors & Cabot Inc. boosted its stake in Intuitive Surgical by 2.3% in the second quarter. Moors & Cabot Inc. now owns 1,159 shares of the medical equipment provider’s stock valued at $516,000 after acquiring an additional 26 shares in the last quarter. Finally, Sargent Investment Group LLC acquired a new stake in Intuitive Surgical in the second quarter valued at approximately $267,000. 83.64% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several brokerages have weighed in on ISRG. Evercore ISI restated a “cautious” rating on shares of Intuitive Surgical in a research note on Friday, October 18th. Leerink Partners raised their target price on shares of Intuitive Surgical from $489.00 to $502.00 in a research note on Thursday, October 17th. Robert W. Baird raised their target price on shares of Intuitive Surgical from $503.00 to $565.00 and gave the company an “outperform” rating in a research note on Thursday, October 17th. The Goldman Sachs Group set a $604.00 target price on shares of Intuitive Surgical in a research note on Friday, October 18th. Finally, Royal Bank of Canada raised their target price on shares of Intuitive Surgical from $525.00 to $555.00 and gave the company an “outperform” rating in a research note on Friday, October 18th. One analyst has rated the stock with a sell rating, four have assigned a hold rating and fifteen have assigned a buy rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $554.17.

Insider Transactions at Intuitive Surgical

In other news, EVP Robert Desantis sold 376 shares of the business’s stock in a transaction dated Friday, November 29th. The shares were sold at an average price of $539.00, for a total transaction of $202,664.00. Following the completion of the sale, the executive vice president now owns 5,506 shares of the company’s stock, valued at $2,967,734. The trade was a 6.39 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, CFO Jamie Samath sold 270 shares of the business’s stock in a transaction dated Tuesday, December 10th. The stock was sold at an average price of $540.15, for a total transaction of $145,840.50. Following the sale, the chief financial officer now directly owns 8,757 shares of the company’s stock, valued at $4,730,093.55. This represents a 2.99 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 48,190 shares of company stock valued at $25,012,927 over the last 90 days. Corporate insiders own 0.80% of the company’s stock.

Intuitive Surgical Stock Performance

ISRG opened at $576.25 on Thursday. Intuitive Surgical, Inc. has a fifty-two week low of $355.17 and a fifty-two week high of $585.50. The company has a fifty day moving average of $537.05 and a two-hundred day moving average of $496.50. The stock has a market capitalization of $205.25 billion, a price-to-earnings ratio of 92.64, a PEG ratio of 4.66 and a beta of 1.39.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings data on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share for the quarter, beating analysts’ consensus estimates of $1.24 by $0.32. Intuitive Surgical had a net margin of 28.51% and a return on equity of 13.41%. The company had revenue of $2.04 billion during the quarter, compared to analysts’ expectations of $2.01 billion. On average, equities research analysts forecast that Intuitive Surgical, Inc. will post 5.45 earnings per share for the current year.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.